Catherine Stavropoulos Giokas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catherine Stavropoulos Giokas has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Efstathios Michalopoulos
Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, Soranou tou Efesiou 4, 115 27 Athens, Greece
1 shared publication - Panagiotis Mallis
Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, Soranou tou Efesiou 4, 115 27 Athens, Greece
1 shared publication - Theofanis Chatzistamatiou
Clinical Biochemistry Laboratory, “Sismanoglio” General Hospital of Attica, Athens, Greece, Greece
1 shared publication
Latest Publications
- Open Access
- 30 June 2021
- Published by Open Exploration Publishing in Exploration of Immunology
- Vol. 1 (2) , 112-139
Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
Mesenchymal stromal cells (MSCs) are a mesodermal stem cell population, with known self-renewal and multilineage differentiation properties. In the last century, MSCs have been widely used in regenerative medicine and tissue engineering approaches. MSCs initially were isolated from bone marrow aspirates, but currently have been identified in a great number of tissues of the human body. Besides their utilization in regenerative medicine, MSCs possess significant immunoregulatory/immunosuppressive properties, through interaction with the cells of innate and adaptive immunity. MSCs can exert their immunomodulatory properties with either cell-cell contact or via paracrine secretion of molecules, such as cytokines, growth factors and chemokines. Of particular importance, the MSCs’ immunomodulatory properties are explored as promising therapeutic strategies in immune-related disorders, such as autoimmune diseases, graft versus host disease, cancer. MSCs may also have an additional impact on coronavirus disease-19 (COVID-19), by attenuating the severe symptoms of this disorder. Nowadays, a great number of clinical trials, of MSC-mediated therapies are evaluated for their therapeutic potential. In this review, the current knowledge on cellular and molecular mechanisms involved in MSC-mediated immunomodulation were highlighted. Also, the most important aspects, regarding their potential application in immune-related diseases, will be highlighted. The broad application of MSCs has emerged their role as key immunomodulatory players, therefore their utilization in many disease situations is full of possibilities for future clinical treatment.
- 30 June 2021
- Published by Open Exploration Publishing in Exploration of Immunology
- Vol. 1 (2) , 112-139
Open AccessInterplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
Mesenchymal stromal cells (MSCs) are a mesodermal stem cell population, with known self-renewal and multilineage differentiation properties. In the last century, MSCs have been widely used in regenerative medicine and tissue engineering approaches. MSCs initially were isolated from bone marrow aspirates, but currently have been identified in a great number of tissues of the human body. Besides their utilization in regenerative medicine, MSCs possess significant immunoregulatory/immunosuppressive properties, through interaction with the cells of innate and adaptive immunity. MSCs can exert their immunomodulatory properties with either cell-cell contact or via paracrine secretion of molecules, such as cytokines, growth factors and chemokines. Of particular importance, the MSCs’ immunomodulatory properties are explored as promising therapeutic strategies in immune-related disorders, such as autoimmune diseases, graft versus host disease, cancer. MSCs may also have an additional impact on coronavirus disease-19 (COVID-19), by attenuating the severe symptoms of this disorder. Nowadays, a great number of clinical trials, of MSC-mediated therapies are evaluated for their therapeutic potential. In this review, the current knowledge on cellular and molecular mechanisms involved in MSC-mediated immunomodulation were highlighted. Also, the most important aspects, regarding their potential application in immune-related diseases, will be highlighted. The broad application of MSCs has emerged their role as key immunomodulatory players, therefore their utilization in many disease situations is full of possibilities for future clinical treatment.